Skip to Main Content

The trade group for generic drug makers has filed a lawsuit charging that a new Maryland law designed to punish companies for price gouging is unconstitutional.

In making its case, the Association for Accessible Medicines argued the law violates interstate commerce by giving Maryland officials the right to govern business outside the state, effectively providing “unprecedented powers to regulate the national pharmaceutical market.” The trade group also maintained the law too vaguely defines “excessive” pricing, which would violate due process.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!